Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Mckeon

Showing results (1-10 of 284) with videos related to

Pageof 29
Sort By:
Continuum (Minneapolis, Minn.)|April 5, 2016
Autoimmune Encephalopathies and DementiasAndrew McKeon
JAMA Neurology|February 7, 2017
Antibody Prevalence in Epilepsy (APE) Score-Evolution in Autoimmune Epilepsy PracticeAndrew McKeon
The Lancet. Neurology|January 8, 2013
The importance of early and sustained treatment of a common autoimmune encephalitisAndrew McKeon
Current Treatment Options in Neurology|June 15, 2013
Immunotherapeutics for autoimmune encephalopathies and dementiasAndrew McKeon
Neurology|November 20, 2021
Glial Fibrillary Acidic Protein Immunoglobulin G in CSF: A Biomarker of Severe but Reversible EncephalitisAndrew McKeon
The Neurohospitalist|August 29, 2013
Paraneoplastic and other autoimmune disorders of the central nervous systemAndrew McKeon
The New England Journal of Medicine|September 23, 2020
Opsoclonus in Anti-Ma2 Brain-Stem EncephalitisAmy Kunchok, Andrew McKeon
Journal of Immunological Methods|May 19, 2026
Novel methods for neural IgG characterization and validation in autoimmune neurologic disordersMichael Gilligan, Andrew McKeon
Handbook of Clinical Neurology|April 27, 2016
Autoimmune movement disordersAndrew Mckeon, Angela Vincent
JAMA Neurology|May 24, 2013
A mild form of adult-onset opsoclonus-myoclonus syndrome associated with antiglutamate receptor antibodies--replyAndrew McKeon, Sean Pittock
Pageof 29

Showing results (1-10 of 284) with videos related to

Sort By:
Pageof 29
Continuum (Minneapolis, Minn.)|April 5, 2016
Autoimmune Encephalopathies and DementiasAndrew McKeon
JAMA Neurology|February 7, 2017
Antibody Prevalence in Epilepsy (APE) Score-Evolution in Autoimmune Epilepsy PracticeAndrew McKeon
The Lancet. Neurology|January 8, 2013
The importance of early and sustained treatment of a common autoimmune encephalitisAndrew McKeon
Current Treatment Options in Neurology|June 15, 2013
Immunotherapeutics for autoimmune encephalopathies and dementiasAndrew McKeon
Neurology|November 20, 2021
Glial Fibrillary Acidic Protein Immunoglobulin G in CSF: A Biomarker of Severe but Reversible EncephalitisAndrew McKeon
The Neurohospitalist|August 29, 2013
Paraneoplastic and other autoimmune disorders of the central nervous systemAndrew McKeon
The New England Journal of Medicine|September 23, 2020
Opsoclonus in Anti-Ma2 Brain-Stem EncephalitisAmy Kunchok, Andrew McKeon
Journal of Immunological Methods|May 19, 2026
Novel methods for neural IgG characterization and validation in autoimmune neurologic disordersMichael Gilligan, Andrew McKeon
Handbook of Clinical Neurology|April 27, 2016
Autoimmune movement disordersAndrew Mckeon, Angela Vincent
JAMA Neurology|May 24, 2013
A mild form of adult-onset opsoclonus-myoclonus syndrome associated with antiglutamate receptor antibodies--replyAndrew McKeon, Sean Pittock
Pageof 29